Results 171 to 180 of about 1,701 (184)

Lenacapavir Approved for HIV but Draws Ire Over Cost

Lancet, The
Sophie Cousins
exaly  

Lenacapavir: A Novel Injectable HIV-1 Capsid Inhibitor

International Journal of Antimicrobial Agents
Wesley Kufel, Allison M Hitchcock
exaly  

Rollout of lenacapavir begins in South Africa

The Lancet Infectious Diseases
openaire   +2 more sources

Lenacapavir: A Novel Long-Acting Capsid Inhibitor for HIV

Annals of Pharmacotherapy
Elizabeth M Sherman, David E Koren, Elias Chahine   +2 more
exaly  

Pharmacokinetics of Long-Acting Lenacapavir in Participants With Hepatic or Renal Impairment.

Antimicrobial Agents and Chemotherapy
Sandhya Girish, Vamshi Krishna Jogiraju, John Ling   +2 more
exaly  

Lenacapavir for HIV Prevention: A Commitment to Equitable Access and Partnership by Gilead Sciences

Clinical Infectious Diseases
Jared M Baeten
exaly  

Rapid Selection of HIV-2 Capsid Mutations in Salvage Therapy With Lenacapavir-Containing Regimen

Clinical Infectious Diseases
Nadia Valin, Sylvie Lariven, Quentin Le Hingrat   +2 more
exaly  

Lenacapavir PrEP roll-out begins in Africa

The Lancet HIV
openaire   +2 more sources

Durability of Lenacapavir in Viremic Heavily Treatment-Experienced People With HIV: Real-World Data From the PRESTIGIO Registry

Journal of Antimicrobial Chemotherapy
Barbara Menzaghi, Vincenzo Spagnuolo, Tommaso Clemente   +2 more
exaly  

A new era in HIV treatment: Evaluating the benefits of lenacapavir

International Journal of STD & AIDS
Sinnha Kumari, Nikil Kumar, Muhammad Saad Khan   +2 more
openaire   +2 more sources